Johnson & Johnson, as the Dow Jones giant promised, announced the start of its Phase 3 testing for its Covid-19 vaccine candidate, looking to enroll 60,000 participants, and JNJ stock rose.

The post Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 Vaccine appeared first on Investor's Business Daily.